Family members ducked responsibility for Purdue’s marketing misdeeds, despite exerting substantial oversight over the company’s management for many years.
Five things for pharma marketers to know: Friday, September 18, 2020
Moderna expects to know if COVID-19 vaccine is safe by Nov.; NY files opioid lawsuit against J&J; #WhoSavesTheirLives: An initiative advocating better support for HCPs.
Five things for pharma marketers to know: Wednesday, September 16, 2020
Court upholds New York law requiring drugmakers to fund opioid programs; More Black and Hispanic children are dying from coronavirus; Eli Lilly’s rheumatoid arthritis drug helps speed recovery in COVID-19 patients.
Five things for pharma marketers to know: Wednesday, August 19, 2020
States seeking $26.4 billion from J&J, distributors in opioid lawsuit; COVID-19 caused a mental health crisis; This year’s flu vaccine push could inform the COVID-19 vaccine effort.
Five things for pharma marketers to know: Tuesday, August 18, 2020
States seek $2.2 trillion from Purdue Pharma; U.S. COVID-19 cases drop, but deaths rise; Opioid prescriptions decrease among Medicare Part D recipients.
Five things for pharma marketers to know: Monday, July 27, 2020
Opioid labels must include information about naloxone; Three of four Americans support mask requirements; Submit a cover design for the MM&M Hall of Femme issue.
Five things for pharma marketers to know: Friday, July 17, 2020
States cut opioid programs as overdoses spike; Novartis pledges to not profit from COVID-19 drugs sent to low-income countries; Walgreens partners with DoorDash to deliver over-the-counter drugs, health products.
Watch: Indivior shows patients on top of their opioid recovery – literally